{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:03:45Z","timestamp":1789830225085,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Instituto de Formaci\u00f3n e Investigacion Marques de Valdecilla (IFIMAV)"},{"name":"Red Tematica de Investigacion en Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Spanish Ministry of Health and Consumer Affairs (RECAVA)"},{"name":"Red de Investigaci\u00f3n en Insuficiencia Cardiaca, Instituto de Salud Carlos III, Spanish Ministry of Health and Consumer Affairs (REDINSCOR)"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ijcard.2013.11.036","type":"journal-article","created":{"date-parts":[[2013,11,23]],"date-time":"2013-11-23T12:03:39Z","timestamp":1385208219000},"page":"15-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?"],"prefix":"10.1016","volume":"171","author":[{"given":"F.","family":"Gonzalez-Vilchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Vazquez de Prada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gomez-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Arizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Almenar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.L.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Perez-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Sanz-Julve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Crespo-Leiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Segovia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lopez-Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Martinez-Dolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mirabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Diaz-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Farrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Blasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2013.11.036_bb0005","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/MOT.0b013e32832e6f7b","article-title":"Renal-sparing strategies in cardiac transplantation","volume":"14","author":"Gustafsson","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0010","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJMoa022171","article-title":"Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients","volume":"3349","author":"Eisen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0015","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","article-title":"Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2years: a randomized clinical trial","volume":"110","author":"Keogh","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0030","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/TP.0b013e3181aacd22","article-title":"Everolimus with reduced cyclosporine versus MMF with standard cyclosporine in de novo heart transplant recipients","volume":"88","author":"Lehmkuhl","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0035","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.healun.2007.03.011","article-title":"Low-dose tacrolimus\/sirolimus and steroid withdrawal in heart recipients is highly efficacious","volume":"26","author":"Meiser","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0040","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.healun.2007.02.008","article-title":"Observational study with everolimus (Certican) in combination with low-dose cyclosporine in de novo heart transplant recipients","volume":"26","author":"Lehmkuhl","year":"2007","journal-title":"J Heart Lung Transplant"},{"issue":"5","key":"10.1016\/j.ijcard.2013.11.036_bb0045","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/ajt.12181","article-title":"Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial","volume":"13","author":"Eisen","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0050","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.healun.2008.07.020","article-title":"Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure","volume":"27","author":"Gonz\u00e1lez-V\u00edlchez","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0055","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MOT.0b013e32834aa2e1","article-title":"De-novo calcineurin-inhibitor-free immunosuppression with sirolimus and mycophenolate mofetil after heart transplantation: 5-year results","volume":"16","author":"Meiser","year":"2011","journal-title":"Curr Opin Organ Transplant"},{"issue":"1","key":"10.1016\/j.ijcard.2013.11.036_bb0060","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1600-6143.2008.02456.x","article-title":"Outcomes following de novo CNI-free immunosuppression after heart transplantation: a single-center experience","volume":"9","author":"Leet","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0070","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0041-1345(03)00772-3","article-title":"Deterioration of renal function after replacement of cyclosporine with sirolimus in five patients with severe renal impairment late after heart transplantation","volume":"35","author":"Zakliczynski","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ejcts.2003.11.030","article-title":"Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients","volume":"25","author":"Groetzner","year":"2004","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0080","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/j.transproceed.2004.10.062","article-title":"Initial experience with sirolimus and mycophenolate mofetil for renal rescue from cyclosporine nephrotoxicity after heart transplantation","volume":"36","author":"Lyster","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0085","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.healun.2005.08.015","article-title":"Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity","volume":"24","author":"Kushwaha","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0090","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/j.1600-6143.2006.01527.x","article-title":"Cyclosporine withdrawal improves renal function in heart transplant patients on reduced-dose cyclosporine therapy","volume":"6","author":"Gleissner","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0095","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/TP.0b013e31821774bd","article-title":"Prospective study of everolimus with calcineurin inhibitor-free immunosuppression in maintenance heart transplant patients: results at 2years","volume":"91","author":"Engelen","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0100","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1016\/j.healun.2005.02.018","article-title":"Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation","volume":"24","author":"Hunt","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0105","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.healun.2007.07.034","article-title":"Sirolimus-based immunosuppression after cardiac transplantation: predictors of recovery from calcineurin inhibitor-induced renal dysfunction","volume":"26","author":"Gustafsson","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.tp.0000276959.56959.69","article-title":"Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients","volume":"84","author":"Raichlin","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0115","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1097\/TP.0b013e31819452ce","article-title":"Progression of renal dysfunction in cardiac transplantation after the introduction of everolimus in the immunosuppressive regimen","volume":"87","author":"Moro Lopez","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0120","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/TP.0b013e3181963371","article-title":"Mycophenolate and sirolimus as calcineurin inhibitor-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure","volume":"87","author":"Groetzner","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0125","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1600-6143.2007.02142.x","article-title":"Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients","volume":"8","author":"Aliabadi","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1399-0012.2009.00963.x","article-title":"Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients","volume":"23","author":"Demirjian","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0135","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.healun.2010.01.005","article-title":"Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation","volume":"29","author":"Gude","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0140","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.healun.2010.11.005","article-title":"Predictors of long-term renal function after conversion to proliferation signal inhibitors in long-term heart transplant recipients","volume":"30","author":"Gonz\u00e1lez-Vilchez","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0145","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1111\/j.1600-6143.2012.04131.x","article-title":"Randomized controlled trial of sirolimus conversion in cardiac transplant recipients with renal insufficiency","volume":"9","author":"Zuckermann","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.trim.2006.02.001","article-title":"Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients","volume":"16","author":"Schweiger","year":"2006","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0160","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1399-0012.2006.00632.x","article-title":"Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients","volume":"21","author":"Potter","year":"2007","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1432-2277.2009.00940.x","article-title":"Reduction of cyclosporine following the introduction of everolimus in maintenance heart transplant recipients: a pilot study","volume":"23","author":"Ross","year":"2010","journal-title":"Transpl Int"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-0012.2011.01407.x","article-title":"Long-term effects on renal function of dose-reduced calcineurin inhibitor and sirolimus in cardiac transplant patients","volume":"26","author":"Khandhar","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0180","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.transproceed.2010.12.055","article-title":"Everolimus plus dosage reduction of cyclosporine in cardiac transplant recipients with chronic kidney disease: a two-year follow-up study","volume":"43","author":"Fuchs","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0190","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1016\/j.transproceed.2009.06.236","article-title":"Usefulness of sirolimus as rescue therapy in heart transplant recipients with renal failure: analysis of the Spanish Multicenter Observational Study (RAPACOR)","volume":"41","author":"Delgado","year":"2009","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0195","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1097\/TP.0b013e3181cbac2d","article-title":"Everolimus with reduced calcineurin inhibitor in thoracic transplant recipients with renal dysfunction: a multicenter, randomized trial","volume":"89","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0200","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1097\/TP.0b013e3181fd01b7","article-title":"Two-year outcomes in thoracic transplant recipients after conversion to everolimus with reduced calcineurin inhibitor within a multicenter, open-label, randomized trial","volume":"90","author":"Gullestad","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/TP.0b013e3181c42b95","article-title":"Cyclosporine lowering with everolimus or mycophenolate to preserve renal function in heart recipients: a randomized study","volume":"89","author":"Potena","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0215","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.healun.2012.01.002","article-title":"Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study","volume":"31","author":"Potena","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0225","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0300-8932(10)70301-8","article-title":"Spanish Heart Transplantation Teams. (Spanish Heart Transplantation Registry. 21th official report of the Spanish Society of cardiology working group on heart failure and heart transplantation (1984\u20132009))","volume":"63","author":"Almenar","year":"2010","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0230","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.healun.2010.08.029","article-title":"Minimizing infection and rejection death: Clues acquired from 19years of multi-institutional cardiac transplantation data","volume":"30","author":"George","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0240","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score method for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D'Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0245","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.jtcvs.2007.07.021","article-title":"Propensity-score matching in the cardiovascular surgery literature from 2004 to 2006: a systematic review and suggestions for improvement","volume":"134","author":"Austin","year":"2007","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0250","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.healun.2011.12.010","article-title":"Improvement in renal function after everolimus introduction and calcineurin inhibitor reduction in maintenance thoracic transplant recipients: the significance of baseline glomerular filtration rate","volume":"31","author":"Arora","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0255","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.healun.2011.10.011","article-title":"Withdrawal of proliferation signal inhibitors due to adverse events in the maintenance phase of heart transplantation","volume":"31","author":"Gonzalez-Vilchez","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.ijcard.2013.11.036_bb0265","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/ndt\/gfh104","article-title":"Propensity scores: help o hype?","volume":"19","author":"Winkelmayer","year":"2004","journal-title":"Nephrol. Dial. Transplant."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313020548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527313020548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T19:55:39Z","timestamp":1539028539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527313020548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0167527313020548"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.036","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of mTOR inhibitors in chronic heart transplant recipients with renal failure: Calcineurin-inhibitors conversion or minimization?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2013.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}